Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Supporting patients in making a clear choice on a nasal decongestant

Download the Supporting patients in making a clear choice on a nasal decongestant poster here.

 

Healthy vs congested nasal passages

Nasal congestion can occur due to infection (such as the common cold, the flu or sinusitis), allergies (such as hayfever), nasal polyps or persistent rhinitis.2 Less common causes include rebound congestion due to decongestant overuse, medication side effects or foreign bodies in the nose.2

 

Why is nasal health important?

 

What are the symptoms of congestion?

Nasal congestion may occur alone or with other symptoms.  Cold and flu and allergic rhinitis also present with symptoms of nasal congestion.4-6

 

What treatment options are available?

Decongestants can provide short-term relief for nasal congestion and are available in many different forms. They can be sold individually or as an ‘all-in-one’ product combined with painkillers or antihistamines.7 Decongestants are available as nasal sprays, nasal drops, tablets, capsules and liquids (syrup).2

Nasal drops and sprays are effective for immediate and quick relief of symptoms. They should only be used for a maximum of 5-7 days due to the risk of rebound congestion.2

Oral decongestants do not work as quickly but may be suitable for use over a longer period of time if necessary.8

 

How do nasal decongestants work?

Decongestants relieve symptoms of nasal obstruction by causing constriction of the blood vessels in the nose. This reduces the swelling and thickness of the nasal mucosa.8

There are a number of decongestants available over-the-counter including:

Pseudoephedrine and phenylephrine are not suitable for use in patients with high blood pressure, heart disease, glaucoma , diabetes, hyperthyroidism, men with an enlarged prostate and people with liver, kidney, heart or circulation problems. When recommending these products it is important to check for interactions with other medicines.10

 

The consultation

A patient-centred approach empowers patients to choose the correct treatment for their symptoms with advice from a healthcare professional. Before recommending any treatments you should ask the following:

  • Who is the treatment for?
  • What are the symptoms?
  • How long have they had symptoms?
  • Have they already taken anything for the symptoms?
  • Are they taking any other medication?

 

 

When to refer patients

Patients should be referred to their GP if symptoms have not improved after one or two weeks despite OTC treatments (treatment duration should not exceed seven days). Other symptoms that would require referral include:2

  • Blood in nasal discharge
  • Only one side of the nose is blocked
  • Patient is unwell with a high temperature
  • Baby has nasal congestion and is having difficulties feeding or breathing
  • Patient feels very unwell or congestion is affecting quality of life.

Refer to product details available on EMC for up to date product information.

 

References

  1. Naclerio RM, et alPathophysiology of nasal congestionInt J Gen Med. 2010;3:47-57. Published 2010 Apr 8. doi:10.2147/ijgm.s8088.
  2. Patient.info (2018) Nasal congestion
  3. Sobiesk JL, et alHead and neck, nasal cavity. [Updated 2020 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan
  4. NHS UK (2019) Non-allergic rhinitis
  5. NHS UK (2017) Common cold
  6. NHS UK (2019) Allergic rhinitis
  7. NHS UK (2019) Decongestants
  8. Patient.info (2018) Decongestants
  9. Patient.info (2020) Ipratropium nasal spray
  10. NHS UK (2019) Pseudoephedrine (including Sudafed)
  11. Electronic medicines compendium (2015) SmPC: Boots blocked nose relief 12mg capsules.
 

Product information

Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution. (0.5 mg/ml xylometazoline hydrochloride and 0.6 mg/ml ipratropium bromide). Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds. Dosage: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Not for use longer than 7 days. Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride or ipratropium bromide or any excipients or hypersensitivity to atropine or similar substances. Patients with glaucoma or rhinitis sicca or following transsphenoidal hypophysectomy or surgery exposing the dura mater. Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, angle closure glaucoma, epistaxis, paralytic ileus, cystic fibrosis. Caution in people sensitive to adrenergic substances, which may cause sleep disturbances, dizziness, tremor, cardiac arrythmias or elevated blood pressure. Hypersensitivity reactions may occur. Do not use for more than 7 days. Use during pregnancy or breastfeeding only if clearly necessary. Avoid contact with eyes. Side effects: See SPC for full details. Hypersensitivity reactions (including angioedema, urticaria and bronchospasm). Localised irritation in the nose and throat, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions, insomnia, fatigue, urine retention and transient visual disturbances. Price: £6.66 (ex. VAT) Legal Status: P. Licence Number: PL 44673/0153. Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel